Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
about
NTRK gene fusions as novel targets of cancer therapy across multiple tumour typesHER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologistsPromoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancerMolecular Testing for Gastrointestinal Cancer.Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.Causes and consequences of nuclear envelope alterations in tumour progression.Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient.Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).Infantile NTRK-associated Mesenchymal Tumors.Identification of NTRK fusions in pediatric mesenchymal tumors.Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy.Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors.Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor.Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.Colorectal cancer genomics and designing rational trials.The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and BeyondThe Winding Roadmap of Biomarkers toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal CancerPATRI, a Genomics Data Integration Tool for Biomarker Discovery
P2860
Q28066821-80D6CD7E-A7EF-4486-AA29-7BB338936B71Q28078111-09EAD9BB-04F1-480D-A96F-FF9786AEADC3Q36350870-0279D9DD-0326-4213-A05E-0497E983101EQ36432094-8F9F108E-5770-465D-AA43-015888C90C27Q37710556-36CFCFA6-AF90-4862-B378-6D5C4BBDD7C0Q38698206-66A75732-144F-4AA4-B925-9F0954F4806DQ38794338-C45A5477-0665-4F73-93F1-93AB2926DF88Q38800617-10A96D4D-683F-4350-8F88-3560811D7641Q38891711-F82D6098-B698-43A2-95E7-C69284B68DEEQ38941928-EA8E5CA3-3490-4F29-A56F-98E84A0F4341Q38956444-83DCF668-6172-46CE-815F-27806354ABD7Q39166808-14674DF3-BF56-4D0D-8A8E-4EEA69CC875EQ41548672-D6EBFC71-25B3-439F-9742-0ACB3C999D0FQ41636361-CF2123D8-351B-431B-9E35-F4EE1255D783Q46044924-5F05CA62-0C02-4A6F-9872-565B752CA2E7Q46229973-BA57AE53-576F-4431-A1D4-36F1FC75010AQ47113874-B4200A4F-2908-44D0-BA21-7154F96AA907Q54981810-EA68B8C3-5985-4A75-86A1-F843A45346F1Q55003763-03E65766-3DA1-418F-AE11-C53D56041A70Q55289701-158C1768-08AD-4237-9F92-28EFEFAD11B8Q55306266-F8B30880-E859-4C55-A81A-46148D269880Q55422121-5598D19D-1FFA-4AA8-AE82-C634AC7C57ECQ58784257-4EBE3686-4952-46F9-9A08-143A00A6B0D8Q58799989-7100D407-E9C7-40DB-A4A7-343131903992Q58883545-2B768A6E-1470-4906-B863-52E42DEBC83E
P2860
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@ast
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@en
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@nl
type
label
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@ast
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@en
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@nl
prefLabel
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@ast
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@en
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@nl
P2093
P2860
P50
P356
P1476
Sensitivity to Entrectinib Ass ...... n Metastatic Colorectal Cancer
@en
P2093
Alessio Somaschini
Antonella Isacchi
Antonella Leone
Arturo Galvani
Cristina Davite
Elena Ardini
Erica Bonazzina
Giovanna Marrapese
Jonathan Lim
P2860
P356
10.1093/JNCI/DJV306
P407
P50
P577
2015-11-12T00:00:00Z